ASCO® 2023 Insights: "A Single-Arm, Open-Label Phase 2 Trial of Doxorubicin + Zalifrelimab With Balstilimab in Pts With Advanced/Metastatic Soft Tissue Sarcomas"

111 views
June 8, 2023
0 Comments
Login to view comments. Click here to Login